211 - Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice

Thursday, October 17, 2024

4:15 PM – 4:30 PM US PT

Location: 403 B

Presenting Author(s)

Nathaniel J. Rhodes, PharmD MS

Associate Professor
Midwestern University
Downers Grove, IL, United States

Slides

Co-Author(s)

Brandon Smith, MD, PharmD

Clinical Assistant Professor of Medicine
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Ryan K. Shields, PharmD, MS

Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Samantha Pan, PharmD (she/her/hers)

PGY-2 Infectious Diseases Pharmacy Resident
Northwestern Memorial Hospital
Chicago, IL, United States
Erin Weslander, PharmD (she/her/hers)

Antimicrobial and Diagnostic Stewardship Coordinator
Northwestern Memorial Hospital
Chicago, Illinois, United States
SG

Shannon Galvin, MD

Associate Professor
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
JH

Jasmine Hughes, PhD

InsightRX
San Francisco, California, United States
Maria-Stephanie Hughes, PharmD (she/her/hers)

Clinical Applications Specialist
InsightRX
Boston, Massachusetts, United States
FS

Fekade B. Sime, PhD, S.Aust.

Research Fellow
Centre for Translational Anti-infective Pharmacodynamics, UQ Centre for Clinical Research
Brisbane, Queensland, Australia
JR

Jason A. Roberts, PhD

NHMRC Leadership Fellow
UQ Centre for Clinical Research, Faculty of Medicine
Brisbane, Queensland, Australia
PK

Patrick J. Kiel, PharmD

Adjunct Clinical Associate Professor of Medicine
Indiana University School of Medicine
Indianapolis, Indiana, United States
Michael N. Neely, MD

Pediatric Infectious Diseases
The Saban Research Institute, Children’s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA
Los Angeles, California, United States
Marc H. Scheetz, PharmD, MSc

Professor and Associate Dean of Research
Midwestern University
Downers Grove, Illinois, United States

Disclosure(s):

Nathaniel J. Rhodes, PharmD MS: Apothecademy, LLC: Advisor/Consultant

Brandon Smith, MD, PharmD: Melinta Therapeutics: Advisor/Consultant; Shionogi, INC: Advisor/Consultant

Ryan K. Shields, PharmD, MS: Allergan: Advisor/Consultant; Cidara: Advisor/Consultant; Entasis: Advisor/Consultant; GSK: Advisor/Consultant; Melinta: Advisor/Consultant, Grant/Research Support; Menarini: Advisor/Consultant; Merck: Advisor/Consultant, Grant/Research Support; Pfizer: Advisor/Consultant; Roche: Grant/Research Support; Shionogi: Advisor/Consultant, Grant/Research Support; Utility: Advisor/Consultant; Venatorx: Advisor/Consultant, Grant/Research Support

Samantha Pan, PharmD: No financial relationships to disclose

Erin Weslander, PharmD: No financial relationships to disclose

Shannon Galvin, MD: No financial relationships to disclose

Jasmine Hughes, PhD: InsightRX: Employee, Stocks/Bonds (Private Company)

Maria-Stephanie Hughes, PharmD: InsightRX: Employee of company, Stocks/Bonds (Private Company)

Fekade B. Sime, PhD, S.Aust.: Gilead: Grant/Research Support; Pfizer: Grant/Research Support

Jason A. Roberts, PhD: No financial relationships to disclose

Patrick J. Kiel, PharmD: Amgen: Employee, Stocks/Bonds (Public Company)

Michael N. Neely, MD: No financial relationships to disclose

Marc H. Scheetz, PharmD, MSc: Abbvie: Advisor/Consultant; Basilea: Advisor/Consultant; Cidara: Advisor/Consultant; DoseMe: Advisor/Consultant; Entasis: Advisor/Consultant; F2G: Advisor/Consultant; GSK: Advisor/Consultant; Lykos: Advisor/Consultant; Roche: Advisor/Consultant; Third Pole Therapeutics: Advisor/Consultant; Xelia: Advisor/Consultant